4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-15-080009
CIK 0001516479operating
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 3:38 PM ET
Size
5.1 KB
Accession
0001209191-15-080009
Insider Transaction Report
Form 4
FOURTEAU PATRICK
Director
Transactions
- Sale
Common Stock
2015-11-12$26.48/sh−30,000$794,400→ 79,682 total
Footnotes (2)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.31 to $26.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 54,841 additional shares.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 3:38 PM ET
- Size
- 5.1 KB